Literature DB >> 8816139

Enterocytozoon bieneusi as a cause of chronic diarrhea in a heart-lung transplant recipient who was seronegative for human immunodeficiency virus.

M Rabodonirina1, M Bertocchi, I Desportes-Livage, L Cotte, H Levrey, M A Piens, G Monneret, M Celard, J F Mornex, M Mojon.   

Abstract

Enterocytozoon bieneusi is a major cause of chronic diarrhea and malabsorption in patients with AIDS. We report what we believe is the first case of intestinal infection due to E. bieneusi in a heart-lung transplant recipient who was seronegative for human immunodeficiency virus (HIV). The clinical presentation and the evolution of the disease were identical to those usually observed in patients with AIDS and included diarrhea, massive weight loss, and persistent infection despite treatment with albendazole. E. bieneusi was identified in the patient's duodenal mucosa by electron microscopy. No other etiologic agent was detected. We conclude that E. bieneusi may be responsible for serious intestinal infections in patients whose immunosuppression is not related to HIV.

Entities:  

Mesh:

Year:  1996        PMID: 8816139     DOI: 10.1093/clinids/23.1.114

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  22 in total

Review 1.  Molecular diagnosis of an Enterocytozoon bieneusi human genotype C infection in a moderately immunosuppressed human immunodeficiency virus seronegative liver-transplant recipient with severe chronic diarrhea.

Authors:  A Sing; K Tybus; J Heesemann; A Mathis
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

2.  Fatal myositis due to the microsporidian Brachiola algerae, a mosquito pathogen.

Authors:  Christina M Coyle; Louis M Weiss; Luther V Rhodes; Ann Cali; Peter M Takvorian; Daniel F Brown; Govinda S Visvesvara; Lihua Xiao; Jaan Naktin; Eric Young; Marcelo Gareca; Georgia Colasante; Murray Wittner
Journal:  N Engl J Med       Date:  2004-07-01       Impact factor: 91.245

3.  One-step purification of Enterocytozoon bieneusi spores from human stools by immunoaffinity expanded-bed adsorption.

Authors:  I Accoceberry; M Thellier; A Datry; I Desportes-Livage; S Biligui; M Danis; X Santarelli
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

Review 4.  First cases of microsporidiosis in transplant recipients in Spain and review of the literature.

Authors:  A L Galván; A M Martín Sánchez; M A Pérez Valentín; N Henriques-Gil; F Izquierdo; S Fenoy; C del Aguila
Journal:  J Clin Microbiol       Date:  2011-02-16       Impact factor: 5.948

5.  Real-time PCR method for detection of Encephalitozoon intestinalis from stool specimens.

Authors:  D M Wolk; S K Schneider; N L Wengenack; L M Sloan; J E Rosenblatt
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

6.  Production and characterization of monoclonal antibodies against Enterocytozoon bieneusi purified from rhesus macaques.

Authors:  Quanshun Zhang; Inderpal Singh; Abhineet Sheoran; Xiaochuan Feng; John Nunnari; Angela Carville; Saul Tzipori
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

7.  Sensitivity and specificity of a monoclonal antibody-based fluorescence assay for detecting Enterocytozoon bieneusi spores in feces of simian immunodeficiency virus-infected macaques.

Authors:  Inderpal Singh; Abhineet S Sheoran; Quanshun Zhang; Angela Carville; Saul Tzipori
Journal:  Clin Diagn Lab Immunol       Date:  2005-10

Review 8.  Molecular techniques for detection, species differentiation, and phylogenetic analysis of microsporidia.

Authors:  C Franzen; A Müller
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

9.  Flow cytometric analysis of microsporidia belonging to the genus Encephalitozoon.

Authors:  D M Moss; G P Croppo; S Wallace; G S Visvesvara
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

Review 10.  Clinical significance of enteric protozoa in the immunosuppressed human population.

Authors:  D Stark; J L N Barratt; S van Hal; D Marriott; J Harkness; J T Ellis
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.